Wang Wei Z, Fang Xin-Hua, Williams Shelley J, Stephenson Linda L, Baynosa Richard C, Khiabani Kayvan T, Zamboni William A
Division of Plastic Surgery, Department of Surgery, University of Nevada School of Medicine, 2040 W. Charleston Blvd., Suite 301, Las Vegas, NV, 89102, USA,
Aesthetic Plast Surg. 2014 Oct;38(5):1017-23. doi: 10.1007/s00266-014-0387-2. Epub 2014 Aug 7.
The purpose for the present study was to determine which anesthetic method, local anesthesia versus tumescent, is superior for liposuction in terms of adipose-derived stem cell (ASC) survival in lipoaspirate; which component, lidocaine versus lidocaine with epinephrine, in anesthetic solutions could affect ASC survival; and which mechanism, necrosis versus apoptosis, is involved in lidocaine-induced ASC death.
Human lipoaspirates were harvested using standard liposuction technique. Individuals scheduled for liposuction on bilateral body areas gave consent and were included in the study. On one area, liposuction was conducted under local anesthesia with lidocaine/epinephrine. On the contralateral area, liposuction was accomplished with tumescent wetting solution containing lidocaine/epinephrine. Lipoaspirates were processed for the isolation of stromal vascular fraction (SVF). ASC survival was determined by the number of adherent ASCs after 24 h of SVF culture. Lidocaine dose-response (with or without epinephrine) on cultured ASCs was examined. Lidocaine-induced ASC apoptosis and necrosis was determined by Annexin V-FITC/Propidium Iodide (PI) assay and analyzed by flow cytometry.
All of the participants were female adults. The average age was 45 ± 4.0 years (±SEM) and the average BMI was 28 ± 1.0 (±SEM). Lipoaspirate samples (n = 14) treated by local anesthesia (n = 7/group) or tumescent anesthesia (n = 7/group) were investigated. Liposuction sites were located in the hip or thigh. The average number of adherent ASCs was 1,057 ± 146 k in the local anesthesia group, which was significantly lower than the 1,571 ± 111 k found in the tumescent group (P = 0.01). ASC survival was significantly lower in the lidocaine group and in a dose-dependent manner as compared to the correspondent PBS controls (P < 0.05 or P < 0.01). ASC survival was significantly lower in both the lidocaine and lidocaine with epinephrine groups when compared to PBS controls. Annexin/PI assay showed that ASC apoptosis (but not necrosis) in the lidocaine group was significantly higher than that in the corresponding PBS control (P = 0.026).
Tumescent anesthesia is the superior method for liposuction with respect to ASC preservation compared to local anesthesia. Lidocaine could cause significant ASC apoptosis.
本研究的目的是确定哪种麻醉方法(局部麻醉与肿胀麻醉)在抽脂术中对抽脂物中脂肪来源干细胞(ASC)的存活更具优势;麻醉溶液中的哪种成分(利多卡因与含肾上腺素的利多卡因)会影响ASC的存活;以及利多卡因诱导ASC死亡涉及哪种机制(坏死与凋亡)。
采用标准抽脂技术采集人体抽脂物。计划在双侧身体部位进行抽脂的个体签署知情同意书并纳入研究。在一个区域,使用含利多卡因/肾上腺素的局部麻醉进行抽脂。在对侧区域,使用含利多卡因/肾上腺素的肿胀液进行抽脂。对抽脂物进行处理以分离基质血管成分(SVF)。通过SVF培养24小时后贴壁ASC的数量来确定ASC的存活情况。检测利多卡因(含或不含肾上腺素)对培养的ASC的剂量反应。通过Annexin V-FITC/碘化丙啶(PI)检测并通过流式细胞术分析来确定利多卡因诱导的ASC凋亡和坏死情况。
所有参与者均为成年女性。平均年龄为45±4.0岁(±标准误),平均BMI为28±1.0(±标准误)。对采用局部麻醉(每组n = 7)或肿胀麻醉(每组n = 7)处理的抽脂物样本(n = 14)进行研究。抽脂部位位于臀部或大腿。局部麻醉组贴壁ASC的平均数量为1,057±146k,显著低于肿胀麻醉组的1,571±111k(P = 0.01)。与相应的PBS对照组相比,利多卡因组的ASC存活率显著降低且呈剂量依赖性(P < 0.05或P < 0.01)。与PBS对照组相比,利多卡因组和含肾上腺素的利多卡因组的ASC存活率均显著降低。Annexin/PI检测显示,利多卡因组的ASC凋亡(而非坏死)显著高于相应的PBS对照组(P = 0.026)。
与局部麻醉相比,肿胀麻醉在抽脂术中对ASC保存方面是更具优势的方法。利多卡因可导致显著的ASC凋亡。